每经AI快讯,康方生物3月30日在港交所公告,2024年,集团总收入为21.24亿元人民币,同比下降53.08%;录得扣除分销成本后的商业销售收入总额为20.02亿元人民币,同比增长24.88%;毛利为18.35亿元人民币,同比减少58.23%。截至2024年12月31日止年度亏损为5.01亿元人民币,截至2023年12月31日止年度盈利为19.42亿元人民币。(文章来源:每日经济新闻)
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.